Get App Open
In App
Open App
you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jun 02, 16:01
637.55 -2.20 (-0.34%)
Volume
AVERAGE VOLUME
5-Day
943
10-Day
1,035
30-Day
2,581
1,091
  • Prev. Close

    639.75

  • Open Price

    641.80

  • Bid Price (Qty.)

    632.95 (1)

  • Offer Price (Qty.)

    641.50 (23)

NSE Live

Jun 02, 15:47
638.20 -2.35 (-0.37%)
Volume
AVERAGE VOLUME
5-Day
27,199
10-Day
21,983
30-Day
48,993
14,078
  • Prev. Close

    640.55

  • Open Price

    634.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2022 2021 2020 2019 2018
Profit & Loss account of Eris Lifesciences (in Rs. Cr.) Mar 23 Mar 22 Mar 21 Mar 20 Mar 19  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,307.12 1,193.77 1,088.65 1,003.76 881.13  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 1,307.12 1,193.77 1,088.65 1,003.76 881.13  
Total Operating Revenues 1,330.73 1,215.73 1,108.83 1,020.23 896.54  
Other Income 17.26 28.99 10.00 14.73 32.50  
Total Revenue 1,347.99 1,244.72 1,118.83 1,034.96 929.04  
EXPENSES  
Cost Of Materials Consumed 114.13 117.57 99.43 76.88 58.19  
Purchase Of Stock-In Trade 113.76 79.59 111.65 70.00 87.56  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade 8.50 2.49 -12.57 17.47 -13.40  
Employee Benefit Expenses 252.52 222.18 207.02 191.73 166.77  
Finance Costs 20.81 2.99 0.78 1.85 22.79  
Depreciation And Amortisation Expenses 64.66 51.46 37.64 44.88 31.59  
Other Expenses 336.71 309.90 285.99 308.54 263.76  
Total Expenses 911.08 786.18 729.94 711.37 617.26  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 436.91 458.54 388.89 323.59 311.78  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 436.91 458.54 388.89 323.59 311.78  
Tax Expenses-Continued Operations  
Current Tax 38.90 80.17 70.18 57.49 68.87  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 0.00 -38.83 -31.90 -25.17 -42.47  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 38.90 41.35 38.29 32.32 26.40  
Profit/Loss After Tax And Before ExtraOrdinary Items 398.01 417.19 350.61 291.27 285.38  
Profit/Loss From Continuing Operations 398.01 417.19 350.61 291.27 285.38  
Profit/Loss For The Period 398.01 417.19 350.61 291.27 285.38  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 29.27 30.70 25.82 21.23 20.75  
Diluted EPS (Rs.) 29.23 30.70 25.80 21.21 20.74  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 81.65 74.68 38.97 0.00  
Tax On Dividend 0.00 0.00 0.00 8.01 0.00  
Equity Dividend Rate (%) 735.00 601.00 550.00 287.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

No News.
No News.
No News.
No News.